Skip to content

Celcuity CELC Interest Income

Interest Income at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$6.25M+16.0%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$5.35M-31.5%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$7.61M+158%
CG Oncology logo
CG OncologyCGON
$6.29M-18.8%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$12.66M-14.6%
Royalty Pharma logo
Royalty PharmaRPRX
$6.23M-44.8%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's interest income?
Celcuity (CELC) reported interest income of $3.75M in Q1 2026.
How has Celcuity's interest income changed year-over-year?
Celcuity's interest income increased by 61.8% year-over-year, from $2.32M to $3.75M.
What is the long-term trend for Celcuity's interest income?
Over 4 years (2021 to 2025), Celcuity's interest income has grown at a 451.8% compound annual growth rate (CAGR), from $13.26K to $12.3M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.